Caballero Nohemi, González-Teshima Laura Yuriko, Arias-Amaya Juan Sebastian, Castaño-Duque Sebastian, González-Uribe Catalina, González Camila, Sarmiento Juliana Helo, Niño-Machado Natalia, Pinilla-Roncancio Mónica
Universidad de los Andes, Bogota, Colombia.
Hospital Universitario San Ignacio, Bogota, Colombia.
BMJ Glob Health. 2025 Apr 28;10(4):e018302. doi: 10.1136/bmjgh-2024-018302.
The incidence of climate-sensitive infectious diseases (CSIDs), such as dengue, chikungunya and Zika, has been rising in Latin America and the Caribbean (LAC). Reported cases of these diseases nearly doubled between 2022 and 2023, with the highest figure reported from Brazil. However, evidence regarding the economic cost of CSIDs is limited in the region. This scoping review aims to identify the available evidence on the economic impacts of CSIDs in LAC countries and the potential costs and benefits of adaptation interventions. We searched PubMed, the Virtual Health Library, Web of Science, Scopus, JSTOR and EconPapers and included peer-reviewed and grey-literature studies published between January 2015 and December 2023. 10 peer-reviewed studies were included in this review: 9 assessed the economic impacts of the health consequences of CSIDs and 1 assessed the economics of adaptation policies or programmes concerning human health in LAC countries. Most studies were conducted in Mexico and Brazil. Studies have focused primarily on the economic costs of arboviruses, influenza and enteritis. The outcomes most frequently studied were disability-adjusted life years and mortality. Only one study evaluated the economic impact of implementing an adaptation intervention for dengue. These findings highlight a significant gap in understanding the economic impacts of CSIDs, particularly because most studies fail to monetise the reported metrics, limiting their ability to provide a comprehensive assessment of economic costs and cost-effectiveness analyses of interventions. There is a need for further research in this field, incorporating data from a diverse range of countries in the region and analysing the economic impacts of various CSIDs, as well as the cost-effectiveness of interventions aimed at reducing their prevalence.
登革热、基孔肯雅热和寨卡等气候敏感型传染病（CSIDs）在拉丁美洲和加勒比地区（LAC）的发病率一直在上升。2022年至2023年期间，这些疾病的报告病例几乎翻了一番，其中巴西报告的病例数最多。然而，该地区关于CSIDs经济成本的证据有限。本范围综述旨在确定拉丁美洲和加勒比地区国家关于CSIDs经济影响的现有证据，以及适应干预措施的潜在成本和收益。我们检索了PubMed、虚拟健康图书馆、科学网、Scopus、JSTOR和EconPapers，并纳入了2015年1月至2023年12月期间发表的同行评审研究和灰色文献研究。本综述纳入了10项同行评审研究：9项评估了CSIDs健康后果的经济影响，1项评估了拉丁美洲和加勒比地区国家人类健康适应政策或计划的经济学。大多数研究在墨西哥和巴西进行。研究主要集中在虫媒病毒、流感和肠炎的经济成本上。最常研究的结果是伤残调整生命年和死亡率。只有一项研究评估了实施登革热适应干预措施的经济影响。这些发现凸显了在理解CSIDs经济影响方面的重大差距，特别是因为大多数研究未能将报告的指标货币化，限制了它们对经济成本进行全面评估和对干预措施进行成本效益分析的能力。该领域需要进一步研究，纳入该地区不同国家的数据，分析各种CSIDs的经济影响，以及旨在降低其流行率的干预措施的成本效益。
